EICHOR
● Completed
A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis
Condition: Bronchiectasis · Sponsor: Boehringer Ingelheim
About this study
This study is open to adults with bronchiectasis. People can join the study if they produce sputum and have a history of flare-ups (also called exacerbations). The purpose of this study is to find out whether a medicine called BI 1291583 helps people with bronchiectasis. Participants are put into 4 groups randomly, which means by chance. Participants in groups 1, 2, and 3 get different doses of BI 1291583. Participants in group 4 get placebo. Placebo tablets look like BI 1291583 tablets, but do not contain any medicine. Participants take the tablets once a day. Participants are in the study for between 6 months and 1 year. During this time, they visit the study site about 10 times and get about 5 phone calls from the site staff. The doctors document when participants experience flare-ups during the study. The time to the first flare-ups is compared between the treatment groups. Doctors also regularly check participants' health and take note of any unwanted effects.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (112)
| Phoenix Medical Group | Peoria, Arizona, United States | — |
| Newport Native MD, Inc | Newport Beach, California, United States | — |
| University of California Davis | Sacramento, California, United States | — |
| Central Florida Pulmonary Group | Altamonte Springs, Florida, United States | — |
| Malcom Randall VA Medical Center | Gainesville, Florida, United States | — |
| University of Florida College of Medicine | Jacksonville, Florida, United States | — |
| University of Kansas Medical Center | Kansas City, Kansas, United States | — |
| New York University Langone Medical Center | New York, New York, United States | — |
| NewYork-Presbyterian/Weill Cornell Medical Center | New York, New York, United States | — |
| Southeastern Research Center | Winston-Salem, North Carolina, United States | — |
| University of Cincinnati | Cincinnati, Ohio, United States | — |
| Medical University of South Carolina | Charleston, South Carolina, United States | — |
+ 100 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05238675